DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
21 11 2022
Historique:
received: 28 03 2021
revised: 01 12 2021
accepted: 13 12 2021
pubmed: 12 1 2022
medline: 24 11 2022
entrez: 11 1 2022
Statut: ppublish

Résumé

DYT6 dystonia is caused by mutations in the transcription factor THAP1. THAP1 knock-out or knock-in mouse models revealed complex gene expression changes, which are potentially responsible for the pathogenesis of DYT6 dystonia. However, how THAP1 mutations lead to these gene expression alterations and whether the gene expression changes are also reflected in the brain of THAP1 patients are still unclear. In this study we used epigenetic and transcriptomic approaches combined with multiple model systems [THAP1 patients' frontal cortex, THAP1 patients' induced pluripotent stem cell (iPSC)-derived midbrain dopaminergic neurons, THAP1 heterozygous knock-out rat model, and THAP1 heterozygous knock-out SH-SY5Y cell lines] to uncover a novel function of THAP1 and the potential pathogenesis of DYT6 dystonia. We observed that THAP1 targeted only a minority of differentially expressed genes caused by its mutation. THAP1 mutations lead to dysregulation of genes mainly through regulation of SP1 family members, SP1 and SP4, in a cell type dependent manner. Comparing global differentially expressed genes detected in THAP1 patients' iPSC-derived midbrain dopaminergic neurons and THAP1 heterozygous knock-out rat striatum, we observed many common dysregulated genes and 61 of them were involved in dystonic syndrome-related pathways, like synaptic transmission, nervous system development, and locomotor behaviour. Further behavioural and electrophysiological studies confirmed the involvement of these pathways in THAP1 knock-out rats. Taken together, our study characterized the function of THAP1 and contributes to the understanding of the pathogenesis of primary dystonia in humans and rats. As SP1 family members were dysregulated in some neurodegenerative diseases, our data may link THAP1 dystonia to multiple neurological diseases and may thus provide common treatment targets.

Identifiants

pubmed: 35015830
pii: 6499999
doi: 10.1093/brain/awac001
doi:

Substances chimiques

Nuclear Proteins 0
DNA-Binding Proteins 0
Apoptosis Regulatory Proteins 0
THAP1 protein, human 0
SP1 protein, human 0
Sp1 Transcription Factor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3968-3984

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Fubo Cheng (F)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
Department of Neurology, The First Hospital of Jilin University, Changchun, China.

Wenxu Zheng (W)

Institute for Ophthalmic Research Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany.

Peter Antony Barbuti (PA)

Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.
Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.

Paola Bonsi (P)

Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.

Chang Liu (C)

Institute of Biology, University of Hohenheim, Garbenstrasse 30, 70599 Stuttgart, Germany.

Nicolas Casadei (N)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
NGS Competence Center Tuebingen, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Giulia Ponterio (G)

Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.

Maria Meringolo (M)

Laboratory of Neurophysiology and Plasticity, IRCCS Fondazione Santa Lucia, Rome, Italy.

Jakob Admard (J)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
NGS Competence Center Tuebingen, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Claire Marie Dording (CM)

Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.

Libo Yu-Taeger (L)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
Department of Human Genetics, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany.

Huu Phuc Nguyen (HP)

Department of Human Genetics, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany.

Kathrin Grundmann-Hauser (K)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Thomas Ott (T)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Henry Houlden (H)

Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.

Antonio Pisani (A)

Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
IRCCS C. Mondino Foundation, Pavia, Italy.

Rejko Krüger (R)

Transversal Translational Medicine, Luxembourg Institute of Health (LIH), Strassen, Luxembourg.
Translational Neuroscience, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg.
Parkinson Research Clinic, Centre Hospitalier de Luxembourg (CHL), Luxembourg.

Olaf Riess (O)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
NGS Competence Center Tuebingen, Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH